Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom

BACKGROUND: Botulinum toxin A (BoNT-A) is an effective treatment for patients with upper limb spasticity (ULS), which is a debilitating feature of upper motor neuron lesions. BoNT-A preparations available in the UK are associated with different costs. METHODS: We developed a budget impact model to a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clinicoecon Outcomes Res
Glavni autori: Abogunrin, Seye, Hortobagyi, Linda, Remak, Edit, Dinet, Jerome, Gabriel, Sylvie, Bakheit, Abdel Magid O
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2015
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4386804/
https://ncbi.nlm.nih.gov/pubmed/25878510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S76141
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items